Bismuth-containing Standard Triple Therapy the First-line Eradication Therapy for Helicobacter pylori
Saved in:
Main Authors: | Yeon-Ji Kim, Woo Chul Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean College of Helicobacter and Upper Gastrointestinal Research
2021-12-01
|
Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
Online Access: | http://www.helicojournal.org/upload/pdf/kjhugr-2021-0027.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tailored Therapy Using Bismuth Add-on Standard Triple Therapy vs. Concomitant Therapy: A First-line Regimen for Helicobacter pylori Infection
by: Soo Yeon Choi, et al.
Published: (2023-06-01) -
Potential Unnecessity of Bismuth in Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori Infection
by: Seon Woo Oh, et al.
Published: (2025-03-01) -
Bismuth, An Indispensable Component of Helicobacter pylori Eradication Therapy
by: Kyung Ho Song
Published: (2023-06-01) -
First-line Helicobacter pylori Eradication with Standard Triple Therapy and Concomitant Therapy: A Retrospective Study
by: Moon Won Lee, et al.
Published: (2018-06-01) -
A 10- or 14-day Bismuth-containing Quadruple Therapy as a First-line Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-analysis
by: Sung Eun Kim, et al.
Published: (2021-03-01)